Literature DB >> 8556717

Primary central nervous system lymphoma in immunocompetent patients.

A J Ferreri1, M Reni, E Villa.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 8556717     DOI: 10.1016/0305-7372(95)90028-4

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  5 in total

1.  Systemic chemotherapy with vincristine, cyclophosphamide, doxorubicin and prednisolone following radiotherapy for primary central nervous system lymphoma: a phase II study.

Authors:  Y Shibamoto; K Sasai; N Oya; M Hiraoka
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

2.  Prevention of recurrence and prolonged survival in primary central nervous system lymphoma (PCNSL) patients treated with adjuvant high-dose methylprednisolone.

Authors:  B P O'Neill; T M Habermann; T E Witzig; M Rodriguez
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

3.  Long-term remission of primary central nervous system lymphoma by intensified methotrexate chemotherapy.

Authors:  Takao Watanabe; Yoichi Katayama; Atsuo Yoshino; Chiaki Komine; Takakazu Yokoyama; Takao Fukushima
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

Review 4.  Second-line treatment for primary central nervous system lymphoma.

Authors:  M Reni; A J Ferreri; E Villa
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

5.  A Case of Primary T-Cell Central Nervous System Lymphoma: MR Imaging and MR Spectroscopy Assessment.

Authors:  G Manenti; F Di Giuliano; A Bindi; V Liberto; V Funel; F G Garaci; R Floris; G Simonetti
Journal:  Case Rep Radiol       Date:  2013-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.